Education and screening for colorectal cancer and hepatitis C

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention promotes concurrent screening for colorectal cancer (CRC) and hepatitis C virus (HCV) among patients aged 45-75 at Federally Qualified Health Centers (FQHCs). The MATCHES program focuses on educating patients about the importance of screening and ensuring they receive the necessary tests. The study aims to improve screening rates by targeting individuals who are not up to date with CRC screening and have never been screened for HCV. The intervention includes providing educational materials and support to facilitate participation in screening.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants must be receiving care at one of the participating FQHC clinics.
* Participants must be 45-75 years of age.
* Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
* Participants must never have had Hepatitis C Virus (HCV) antibody screening.
* Participants must be able to read, write, and understand English or Spanish.
* Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
* Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
* Participants must be asymptomatic for HCV.
* Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
* Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
* Participants completing qualitative interviews must be willing to be audio recorded.
* Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
* All Participants must be able to provide informed consent.

Exclusion Criteria:

* Participants that do not meet all Inclusion Eligibility requirements will be excluded.

Where it's running

• Moffitt Cancer Center
  Tampa, Florida, United States Recruiting

Study contacts

• Principal investigator: Shannon Christy, PhD — Moffitt Cancer Center
• Study coordinator: Carol Boxtha
• Email: Carol.Boxtha@Moffitt.org
• Phone: 813-745-8963

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Electrolyte beverage plus PEG for colonoscopy bowel prep

  This randomized trial tests different mixes of electrolyte drink and water with PEG to see which bowel prep regimen gives the best cleansing for adults getting colonoscopy.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07608120

• Using prior CT scans to guide colonoscope insertion

  This trial will test whether using a patient's existing abdominal/pelvic CT scan to guide colonoscope insertion makes colonoscopy faster and more comfortable for adults having screening or diagnostic colonoscopy.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07541924

• Animated storytelling video to boost colorectal cancer screening

  A short animated video is being tested to see if it makes adults in the U.S. who haven’t been screened more likely to plan getting screened for colorectal cancer.

  Recruiting Stanford University · Stanford, California · NCT07522177

• Does GP endorsement and early information improve colonoscopy follow-up after a positive colorectal cancer screening test?

  This study tests whether giving patients early information about colonoscopy and having their GP endorse the follow-up can increase how many people in France get a colonoscopy within six months after a positive screening result.

  Recruiting Phase 3 University Hospital, Caen · Tours, France · NCT07520578

• Pilot of a colorectal cancer education program

  This program will test whether a culturally and language‑targeted education program helps adults aged 45–75 who are overdue for colorectal cancer screening complete recommended screening.

  Recruiting NYU Langone Health · New York, New York · NCT07361614

• Noninvasive blood miRNA test to screen for multiple gastrointestinal cancers.

  This project will test whether a blood-based microRNA panel can detect several types of gastrointestinal cancer in adults using stored blood samples.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07224750

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.